September 24-28, 2018
Philadelphia Convention Center, Philadelphia

Media Center

2017 Global Forum Event Brochure

New city, new look, same remarkable event! We're headed to Chicago this year with a new look, new speakers and new content, making your experience at the Global Forum more valuable than ever before.

Keynote speakers include:

  • Paul Zikopolous, VP of Competitive and Big Data Analytics Teams and Future Trends Expert, IBM
  • Wesley Schmidt, Vice President of Quality Systems, AbbVie
  • John Brownstein PhD, Chief Innovation Officer & Professor, Boston Children’s Hospital & Harvard University
  • Bradford Stewart, Global Security Operations Center Manager, Alexion Pharmaceuticals and Former Chief of Staff to the President’s Daily Brief
  • Rey Chern, Director of Engineering, Amgen
  • Rick Calabrese, Global Director of Corporate Quality Systems, Sartorius Stedim North America Inc.
  • Rakesh Shah, Director Supply Chain- APAC (Sub Region II), India and Frontier Market, Merck Serono
  • Lisa Wyman, Head of Quality Compliance & Data Analytics, Shire Pharmaceuticals
  • Ben Romero, Director Logistics Temperature Control, Bristol-Myers Squibb

View the 2017 event brochure and reach out to us to register at

Fast Track Your Attendance

Past Attendee Snapshot

We are expecting experienced temperature controlled life science professionals from a variety of different areas at the Cold Chain Global Forum. Take a look at the professionals you'll see on the show floor this September.

To receive our past attendee list via email, contact us at

2017 Global Forum Post Show Report

Find out who joined us at the 2017 Annual Global Forum and how they benefited from attending! Our 2017 post show report includes:

  1. 2017 Attendee Demographics
  2. 2017 Attendee Job Titles & Companies
  3. Attendee Testimonials
  4. 2017 Global Forum Excellence Award Winners

To receive our Post Show Report via email, please contact us at

Dear Boss Letter

Fast track your attendance to the 2018 Global Forum with our customizable Dear Boss Letter.

Attendee ROI Toolkit: Build Your Business Case to Attend the 2018 Global Forum!

Your one-stop-shop for justifying your attendance to the 2018 Global Forum, this packet includes:

  • Past Attendee List
  • Dear Boss Letter
  • Registration Form

Exclusive Content

IBM's Breakthrough: Watson May Help Beat Cancer

Our 2017 Keynote Speaker, Paul Zikopoulous, VP Big Data & Cognitive Systems at IBM, shared with us this Bloomberg clip of IBM Watson and how it may help beat cancer. This will be a focus of Paul's keynote session "The Big Data Revolution" at the 15th Annual Global Forum. View the news clip & get a preview of what Paul will be discussing this year in Chicago!

CNBC: "When Big Tech Companies Want to Get Into Health, They Call this Harvard Researcher"

John Brownstein, Chief Innovation Officer at Boston Children's Hospital & Professor at Harvard University, was featured on CNBC for his work with Uber. Due to his innovative idea of how to change the way patients receive prescriptions, Uber created UberHEALTH. He's also worked with Google, Twitter and Yelp to find new breakthroughs in the health sector. Check out the article before joining us for John's session at the 15th Annual Global Forum!


Whitepaper: End-to-End Supply Chain Visibility

Visibility provides a number of returns for pharma firms. Henrik Fröjdh, Associate Director of Supply Chain Management at Merck said that inventory reduction was one of the biggest drivers for Merck’s business case for supply chain visibility. With a better understanding of the supply chain, shippers can manage risks proactively. The tracking required in serialization projects greatly enhances supply chain visibility levels. Embedded sensors right down to the individual product gives live location and safety information. This refined clarity places more control and actionable information at the hands of supply chain stakeholders for forecasting to enhance the network’s efficiency.

View the whitepaper for a deeper dive into end-to-end supply chain visibility. Email for an emailed copy.

Sponsorship Information

Global Forum Annual Exhibition Floor Plan

Take a look at this year's floor plan to see which exhibition spaces are still available!

Exclusive Content

Disruption in the Pharma Industry

<p>What will technologies will disrupt the life sciences supply chain industry in 2018? To find out, we sat down with Paul Zikopoulos, VP of Competitive and Big Data Analytics Teams and Future Trends Expert, IBM, and the 2017 Global Forum's keynote speaker.</p>


Top Challenges Report: Supplying Next Generation Medicines

The personalized medicines market – which tailors drugs and treatments to the individual patient – is expected to reach revenues of $149 billion by 2020, according to Pharmaceutical Commerce. And the rising use of biosimilars – a biologic medical product that is a near-identical copy of an original product by another company – is expected to result in the near doubling of the size of pharma cold chain logistics business over the next three years.

We sat down with Catherine Coppage, Supply Chain Planner, Personalized Medicines at Kiadis Pharma; Javier Gomez-Contreras, Supply Chain BGx LATAMOE Latina-Mid East Africa-India & Asia Pacific Lead at GlaxoSmithKline; and Jeremy Cress, Director Of Operations, Fibrocell Science to dive into  the challenges and opportunities distributing personalized medicines present.


The Best of 2016! - The CCGF Highlight Reel

The 2016 Cold Chain Global Forum was our best event yet! With a world-class speaking faculty, and unparalleled in-depth content, CCGF is the #1 event in the cold chain industry.

Gilles Jr. Gregoire - Temperature Controlled Supply

Join Gilles Jr. Gregoire, Global Transport Manager, Pharmascience as he discusses topics that include; the 3 biggest cold chain packaging trends of 2017, real time temp monitoring technologies, the growing trend towards “direct to patient” deliveries and much more.

Claude Jolicoeur - Data Sharing and Temp Monitoring Tech

Join Claude Jolicoeur, Director of Regulatory Affairs, McKesson Canada Corp as he discusses topics that include; changes within the supply chian industry on capturring and shareing data, real time temp monitoring technologies,cold chain challenges wihtin the Canadian market and much more.

Andrea Guisbert-Williams - Cost Savings & Sustainability Through a Switch from Air to Ocean

Join Andrea L. Guisbert-Williams, Project Manager, North American Logistics Operations, Eli Lilly & Company in an exclusive interview about the effect of growth of biologic based products on temp controlled operations, next generation medicines, and her case study, Discovering Eli Lilly’s Plan to Achieve Cost Savings & Sustainability Through a Switch from Air to Ocean.


Digitization and Big Data's Impact on the Pharma Supply Chain

Pharma and biotech organizations are beginning to implement some of the market’s newest technologies to enhance how they make decisions and predict outcomes in the supply chain. Take a look at stats on digitization and big data’s impact on current and future pharma supply chains.


Whitepaper: Insights from the Experts

It's an innovative time in the industry as new technologies are changing the supply chain and business are trying to find new ways to get their products where they need to be faster, more efficiently while saving money. See what executives from Merck, Amgen, Zogenix, Marketing Association, Eli Lilly, GlaxoSmithKline and more are saying about the current state of the industry, future trends, and what they look forward to most about the Global Forum.

Managing the Challenges of Controlled Room Temperature Requirements in Cold Chain Pharmaceutical Distribution

<p>Pelican BioThermal is a participating sponsor of the 15th Annual Global Forum. Read their white paper here and be sure to stop by their booth at the event in September.</p>

Whitepaper: Moving the Industry Towards Collaboration

Collaboration has long been considered an effective approach and is employed by many highfunctioning organizations. In business and in communities, the strategic value of aligning yourself with other groups that have a shared vision, where each collaborator brings something to the table and is willing to work together to get there is now seen. Collaboration between different groups - within and outside the enterprise – makes for a changed dynamic. It is a commonly held view that stakeholders in collaboration are at their best, fully invested and engaged, even if conflict situations arise. This whitepaper dives into how collaboration is effective for the pharmaceutical supply chain industry.

Clinical Trial Supply 2018 Report: The Quest To Shrink Wastage Levels

In meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply already suffers from major issues with wastage levels. This is lack of control is problematic with the rising public scrutiny on spending by pharmaceutical companies.

Forecasting and demand planning

When sites are under supplied, sponsors may be forced to halt enrolment or even freeze patient treatments. This could have a large influence on the outcomes of a trial. Due to a range of factors, study design, patient enrolment, quantity of sites, site location, that can suddenly change the level of supplies needed for a trial to run, supply managers reduce the risk of stock outs by supplying a surplus of medicine. This in many cases spills over to become overage – when the investigational medicines have to be wasted at the end of a trial or hit their expiry dates before consumption.

Global Forum Content Pack: Top Industry Content

As we gear up for the 15th Annual Global Forum, we're re-releasing some of the most well received industry content from last year's event.

Take a look at our Global Forum Content Pack or request an emailed copy that includes:

  • In-depth report on "Standardization and Risk Management in the Cold Chain"
  • Best Practice Guidebook for "Packaging Design & Qualification in Temperature Controlled Logistics"
  • Global Mastery eBook featuring interviews with Eli Lilly, Amgen, McKesson, Novartis LatAm and many more

2016 Pharmaceutical Cold Chain Market Report

Last year, we put together the comprehensive 2016 Pharmaceutical Cold Chain Market Report detailing major and emerging trends in the industry, and how the industry is reacting to these changes. The report includes expert interviews and insights, case studies, information on the industry's biggest challenges and investment areas and more. View the report and stay tuned for more information on the industry leading up to the 15th Annual Global Forum!

Sponsorship Information

Video: A Spotlight On Our Sponsors

The Cold Chain Global Forum is the largest exhibition of solutions and services for temperature controlled life science products. Don't just take our word for it - see and hear it for yourself, we guarantee you'll be impressed.


The Benefits of Blockchain: Fact or Wishful Thinking?

The basics: Blockchain is still a largely unproven innovation in the supply chain, but it’s also one that companies can’t afford to ignore. This first part of four in this issue of NextGen Supply Chain details what the technology is and how it works to make the supply chain more effective.

NextGen Supply Chain: The Robots are Here

Long a fixture on the factory floor, a new generation of robots are ready for a broader range of applications. The only thing standing in their way is end-user adoption.

8 Fundamentals for Achieving AI Success in the Supply Chain

In the race to use AI, many companies have made attempts to implement it, but the results have been disappointing.


The DSCSA’s Impact on the Global Supply Chain: A Breakdown of the Regulations, Deadlines, and What the Supply Chain will Look Like in a Post-Serialized World

  • Examine the full scope of DSCSA requirements and top international serialization deadlines that are looming How can logistics professionals support serialization teams past the 2017 deadline
  • What application does serialization technology have for temperature monitoring? Can they work in tandem?
  • Predicting how a post-serialized world will affect the pharma supply chain

Presentation by Matt Sample Sr. Director, Secure Supply Chain AmerisourceBergen Corporation

2017 Presentations

Building an Integrated Risk Management Framework in your Company to Allow for Increasingly Effective Decision Making

  • Proactively minimize risks to patients, operations, and supply chain through early identification, detection and mitigation
  • End-to-end risk review and control of products throughout the supply chain
  • Drive continual improvement throughout the product and process lifecycle to ensure a reliable supply of quality products to patients Leverage risk management tools to make risk based decisions in temperature controlled distribution

Presentation by Lisa Wyman Head of Quality Compliance & Data Analytics Shire Pharmaceuticals

Optimizing the Supply Chain with Passive Pallet Solutions; Reducing Costs While Improving Ergonomics and Availability

  • Evaluation of existing and potential passive and active pallet shipping solutions Walk through analysis of pallet solutions utilizing criteria such as cost savings, ergonomics, and additional supply initiatives
  • Review the expedited customization process of a standard product offering to meet ergonomic and performance requirements
  • Overview of the implementation strategy and the opportunities for reuse.

Presentation by:

Bryan Cardis, Distribution Platform Steward – Global Packaging, Eli Lilly & Company

Christopher Lyons, PE Consultant, Package Engineering, North American Logistics Operations Eli Lilly & Company

Stephen Kolb, Business Development Manager, Cold Chain Technologies

Understanding the New Regulatory Provisions Outlined in Health Canada Guide-0069

  • Review guidelines for products in transit: stability data requirements and temperature mapping
  • Discuss the regulatory scope of temperature monitoring for CRT Hear recommended approaches for risk evaluation and mitigation and analyze examples of compliance and non-compliance
  • Take a look at what Roche implement locally to distribute to our Canadian customers to fulfill the authority requirements

Presentation by Tonino Antonetti Executive Director, Regulatory Affairs, Quality Management, Safety & Health and Environment Roche Diagnostics Canada

State of the Industry: Addressing the Unmet Medical Needs of Patients’ Globally through Industry Collaboration & Supply Chain Innovation

  • Review the international landscape of rare disease treatment & new medicines entering the supply chain to treat them How have regulations in both the US & abroad impacted the industry’s ability to reach patients
  • Discuss how new technological innovations and supply chain collaboration can make reaching challenging markets more feasible
  • Where is the industry headed next? How is the temperature controlled supply chain an integral part of the future?

Presentation by Wesley Schmidt, Vice President of Quality Systems, AbbVie

You Work Hard to Get your Data, Now Make your Data Work Hard for You Part 2: Ambient Temperature Profile Generation and its Effect on Passive Shippers

An overview of Eli Lilly’s Initiatives for Increasingly Effective Lane Data Analysis. Hear how Eli Lilly is using climate data to design containers for the varying seasons through simulations & pilots. Find out how to use weather data to come up with test profiles and gather lane data in a targeted way.

Presentation by Bernard McGarvey, Ph.D. Sr. Engineering Advisor, Eli Lilly and Company

You Work Hard to Get your Data, Now Make your Data Work Hard for You Part 1: Exploring BMS' Initiatives for Increasingly Effective Lane Data Analysis

You Work Hard to Get your Data, Now Make your Data Work Hard for You! Hear how BMS is characterizing lanes for shipping through gathering detailed shock & vibration data. Review their goal to eliminate the need to ship actual product PQ. Presentation by Carolyn Williamson, Principal Packaging Engineer, Bristol-Myers Squibb.

USP <1079> and the Evolution of Good Distribution Processes: Enhancing Quality Assured Processes to Maintain Product and Supply Chain Integrity through Advanced Risk Mitigation Techniques

Review the increased globalization of the pharmaceutical industry and its impact on the handling, storage, and distribution of products.

  • Take a life cycle management approach to quality, ranging from material procurement to manufacturing to delivery of a final product to the patient
  • Ensure each activity in the distribution of a product is carried out according to the principle of Good Distribution Practices (GDP)
  • Identify common risks in the storage and transportation of finished drug products and recommended mitigation strategies for these risks

Presentation by Chris J Anderson, Director, Quality Systems, Cardinal Health, USP Packaging and Distribution Expert Committee Member USP Sub-Committee Co-Chair, U.S. Pharmacopeia.

Building an Organizational Standard Across your Global Departments to Achieve Resiliency, Agility & Cost Savings throughout your Supply Chain Processes

  • Create a global team between quality, supply chain, logistics, and packaging to streamline transportation challenges yielding cost savings Implement governance and address the nuances in global GDP regulations by setting an internal standard at the most stringent level
  • Complete a GAP analysis of your different product lines to determine where issues may occur
  • Collaborate with suppliers to provide visibility on the inbound for raw materials and semi finished goods for PO’s throughout the entire life cycle as well as forecast

Presentation by Dan Mirica, Former Head of Global Logistics, Lonza Biologics

Managing Contingencies to Minimize Risk of Highly Sensitive Medications during End-to-End Clinical & Commercial Distribution

  • Discuss at-home and in-clinic portable 2-8°C and CRT storage, with continuous real-time temperature monitoring and inventory management using RFID technology
  • End to end traceability and excursion management leads for efficient QA oversight and release which can be achieved from point of manufacture, packaging through patient treatment Review logistical route planning and contingency considerations to minimize risk and loss of highly sensitive medications
  • Case studies: Demonstrate successful solutions for the most challenging routes, temperature requirements and complex delivery, including direct to patient and import scenarios
  • Technology demonstration of the CubixxCT and cloud based portal

Presentation by Dustin Roller VP of Innovation Product Development ASD Healthcare

Mitigating Import/Export Complexities in the Indian & APAC Regions

  • Discuss methods for working around customs challenges leading to potential shipment delays
  • How to best interpret the regulations and remain compliant from API’s to finished drug products
  • How to work closely with your supply chain partners to ensure SOP’s are being met in these regions
  • Hear about potentially temp controlled warehousing options within the regions as a method to mitigate delays within transit

Presentation by Javier Gomez-Contreras Supply Chain BGx LATAM- OE Latina-Mid East Africa- India & Asia Pacific Lead GSK

2016 Presentations

Bristol-Myers Squibb: Evaluating the Cost and Operational Efficiency of Greener Packaging Insulation Materials

In her session at the 14th Cold Chain Global Forum, Beth Ruland discusses the scope of the project BMS underwent, design evaluation and the results of assessing the quality and environmental benefits of switching from foam insulation. She discussed the signicant cost savings and also touches on next steps for BMS. View her session PPT to learn more!

Bill & Melinda Gates Foundation: Immunization Supply Chain 2020

At the 14th Cold Chain Global Forum, Raja Rao discussed the status of immunization programs in the developing world, current supply chain issues and what threats it may pose to industry progress. He also discussed the current Gates Foundation actions on supply systems and cold chain strengthening and bringing together new cold chain technology, markets, incentives and sound measurement to create results. View his session presentation!

Eli Lilly: Inside the Company's Implementation of Reusable Shipping Containers

At the 14th Cold Chain Global Forum, Christopher Lyons and Bryan Cardis explored the key considerations in adopting reuse and recycling programs for single-use passive coolers. View the PPT of their session!